Literature DB >> 19512958

Etoposide pathway.

Jun Yang1, Alessia Bogni, Erin G Schuetz, Mark Ratain, M Eileen Dolan, Howard McLeod, Li Gong, Caroline Thorn, Mary V Relling, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19512958      PMCID： PMC4164627          DOI： 10.1097/FPC.0b013e32832e0e7f

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  23 in total

1.  Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.

Authors:  M J Ratain; L S Kaminer; J D Bitran; R A Larson; M M Le Beau; C Skosey; S Purl; P C Hoffman; J Wade; J W Vardiman
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

2.  Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase.

Authors:  V E Kagan; A I Kuzmenko; Y Y Tyurina; A A Shvedova; T Matsura; J C Yalowich
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

3.  Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26).

Authors:  N Haim; J Roman; J Nemec; B K Sinha
Journal:  Biochem Biophys Res Commun       Date:  1986-02-26       Impact factor: 3.575

4.  Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints.

Authors:  B D Lovett; D Strumberg; I A Blair; S Pang; D A Burden; M D Megonigal; E F Rappaport; T R Rebbeck; N Osheroff; Y G Pommier; C A Felix
Journal:  Biochemistry       Date:  2001-02-06       Impact factor: 3.162

5.  Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).

Authors:  N Zelcer; T Saeki; G Reid; J H Beijnen; P Borst
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

6.  Kinetics and regulation of cytochrome P450-mediated etoposide metabolism.

Authors:  Xiaoliang Zhuo; Naiyu Zheng; Carolyn A Felix; Ian A Blair
Journal:  Drug Metab Dispos       Date:  2004-09       Impact factor: 3.922

7.  Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.

Authors:  Shinji Kishi; Wenjian Yang; Benoit Boureau; Stanislas Morand; Soma Das; Peixian Chen; Edwin H Cook; Gary L Rosner; Erin Schuetz; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

8.  Metabolism and excretion of etoposide in isolated, perfused rat liver models.

Authors:  K Hande; R Bennett; R Hamilton; T Grote; R Branch
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

9.  Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.

Authors:  Yuichiro Watanabe; Miki Nakajima; Noriko Ohashi; Toshiyuki Kume; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2003-05       Impact factor: 3.922

Review 10.  Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

Authors:  J Yang; A Bogni; C Cheng; W K Bleibel; X Cai; Y Fan; W Yang; J C C Rocha; D Pei; W Liu; M E Dolan; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2008-05-28       Impact factor: 6.875
View more
  14 in total

1.  PharmGKB summary: very important pharmacogene information for GSTT1.

Authors:  Caroline F Thorn; Yuan Ji; Richard M Weinshilboum; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-08       Impact factor: 2.089

2.  PharmGKB: the Pharmacogenomics Knowledge Base.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Methods Mol Biol       Date:  2013

Review 3.  Glutathione efflux and cell death.

Authors:  Rodrigo Franco; John A Cidlowski
Journal:  Antioxid Redox Signal       Date:  2012-07-16       Impact factor: 8.401

4.  A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer.

Authors:  Ioannis A Voutsadakis
Journal:  Eur J Breast Health       Date:  2018-01-01

Review 5.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

6.  Natural variation in a single amino acid substitution underlies physiological responses to topoisomerase II poisons.

Authors:  Stefan Zdraljevic; Christine Strand; Hannah S Seidel; Daniel E Cook; John G Doench; Erik C Andersen
Journal:  PLoS Genet       Date:  2017-07-12       Impact factor: 5.917

Review 7.  Physiological Roles of DNA Double-Strand Breaks.

Authors:  Farhaan A Khan; Syed O Ali
Journal:  J Nucleic Acids       Date:  2017-10-18

8.  DNA damage response induced by Etoposide promotes steroidogenesis via GADD45A in cultured adrenal cells.

Authors:  Mimi Tamamori-Adachi; Akane Koga; Takao Susa; Hiroko Fujii; Masao Tsuchiya; Hiroko Okinaga; Harumi Hisaki; Masayoshi Iizuka; Shigetaka Kitajima; Tomoki Okazaki
Journal:  Sci Rep       Date:  2018-06-25       Impact factor: 4.379

9.  Downregulation of the inflammatory network in senescent fibroblasts and aging tissues of the long-lived and cancer-resistant subterranean wild rodent, Spalax.

Authors:  Amani Odeh; Maria Dronina; Vered Domankevich; Imad Shams; Irena Manov
Journal:  Aging Cell       Date:  2019-10-11       Impact factor: 9.304

10.  Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.

Authors:  Sook Wah Yee; Joel A Mefford; Natasha Singh; Mary-Elizabeth Percival; Adrian Stecula; Kuo Yang; John S Witte; Atsushi Takahashi; Michiaki Kubo; Koichi Matsuda; Kathleen M Giacomini; Charalambos Andreadis
Journal:  J Hum Genet       Date:  2013-05-16       Impact factor: 3.172
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.